dexamethasone sodium phosphate (51662-1432)

Drug Facts

Product Profile

Brand Name dexamethasone sodium phosphate

Generic Name dexamethasone sodium phosphate

Labeler hf acquisition co llc, dba healthfirst

Dosage Form INJECTION, SOLUTION

Routes

INTRA-ARTICULAR INTRALESIONAL INTRAMUSCULAR INTRAVENOUS SOFT TISSUE

Active Ingredients

dexamethasone sodium phosphate 4 mg/mL

Manufacturer

HF Acquisition Co LLC, DBA HealthFirst

Identifiers & Regulatory

Product NDC 51662-1432

Product ID 51662-1432_2b3940eb-d1f0-e916-e063-6294a90a2f03

Product Type HUMAN PRESCRIPTION DRUG

Marketing Category ANDA

Application Number ANDA206781

Listing Expiration 2026-12-31

Marketing Start 2019-12-21

Pharmacologic Class

Classes

corticosteroid hormone receptor agonists [moa] corticosteroid [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 516621432

Hyphenated Format 51662-1432

Supplemental Identifiers

RxCUI

1116927

UPC

0355150239306

UNII

AI9376Y64P

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name dexamethasone sodium phosphate (source: ndc)

Generic Name dexamethasone sodium phosphate (source: ndc)

Application Number ANDA206781 (source: ndc)

Routes

INTRA-ARTICULAR INTRALESIONAL INTRAMUSCULAR INTRAVENOUS SOFT TISSUE

source: ndc

Resolved Composition

Strengths

4 mg/mL

source: ndc

Packaging

30 mL in 1 VIAL, MULTI-DOSE (51662-1432-1)

source: ndc

Packages (1)

51662-1432-1 30 mL in 1 VIAL, MULTI-DOSE (51662-1432-1)

Ingredients (1)

dexamethasone sodium phosphate (4 mg/mL)

Linked Drug Pages (1)

DEXAMETHASONE SODIUM PHOSPHATE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload

{"route": ["INTRA-ARTICULAR", "INTRALESIONAL", "INTRAMUSCULAR", "INTRAVENOUS", "SOFT TISSUE"], "spl_id": "2b3940eb-d1f0-e916-e063-6294a90a2f03", "openfda": {"upc": ["0355150239306"], "unii": ["AI9376Y64P"], "rxcui": ["1116927"], "spl_set_id": ["9a426a16-19f8-567e-e053-2a95a90a0a5b"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "30 mL in 1 VIAL, MULTI-DOSE (51662-1432-1)", "package_ndc": "51662-1432-1", "marketing_start_date": "20191221"}], "brand_name": "DEXAMETHASONE SODIUM PHOSPHATE", "product_id": "51662-1432_2b3940eb-d1f0-e916-e063-6294a90a2f03", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Corticosteroid Hormone Receptor Agonists [MoA]", "Corticosteroid [EPC]"], "product_ndc": "51662-1432", "generic_name": "DEXAMETHASONE SODIUM PHOSPHATE", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "DEXAMETHASONE SODIUM PHOSPHATE", "active_ingredients": [{"name": "DEXAMETHASONE SODIUM PHOSPHATE", "strength": "4 mg/mL"}], "application_number": "ANDA206781", "marketing_category": "ANDA", "marketing_start_date": "20191221", "listing_expiration_date": "20261231"}